CXCL9 and metabolic dysfunction-associated steatohepatitis: To verify the enhanced expression patterns of five SWDEGs in NASH and IBD patients, immunofluorescence analysis was conducted to examine the expression of CXCL9, ADAMTS5, GIMAP2, GRA, PRF1, and F4/80 (a marker for macrophages) in our collected human samples.